About GLSG
Connecting International biotech startups to the US market with expert guidance
Abstract
Connecting global biotech startups with premier US market opportunities. GLSG delivers specialized consulting services to biotech companies, investors, and stakeholders across Boston and Maryland innovation hubs.
Keywords: biotech consulting · soft landing · Boston/Cambridge · Maryland · Korea · Europe · US market penetration · business development
The GLSG corridor
Select or hover a region — Korea, Europe, or the United States — to see how GLSG connects it to the Boston and Maryland hubs.
What We Do
Connecting global biotech startups with premier US market opportunities.
1.1 — Method
US Market Penetration
Navigating the US market with expert strategic guidance.
1.2 — Method
Business Development
Fundraising strategies and investment-readiness.
Connecting Korea-Boston-Maryland-Europe
1.3 — Method
Soft Landing
Soft landing to the central hub of life sciences, Boston.
Who This Serves
Three audiences meet at the same gateway, in order of priority.
2.1 — Audience
Korean Companies
Korean life-science companies entering the US market: soft landing to Boston, market entry, entity setup, and cross-border operations guided step by step from Boston to Maryland.
2.2 — Audience
Investors in America and Europe
A vetted cross-border pipeline of high-potential startups sourced in Korea and Europe, presented investor-ready — with capital strategy and milestone plans that resonate with U.S. investors.
2.3 — Audience
European Companies
European life-science companies use the same Boston and Maryland gateway: soft-landing infrastructure, partner introductions, and long-term US ecosystem integration.
Discussion
Advancing Biotech Innovation Through Strategic Expertise
GLSG delivers specialized consulting services to biotech companies, investors, and stakeholders across Boston and Maryland innovation hubs.
Contact
Reach out to GLSG for tailored biotech guidance.